Miconazole mucoadhesive tablets: A novel delivery system

José A. Vazquez, Jack D. Sobel

Research output: Contribution to journalReview article

18 Scopus citations

Abstract

Oropharyngeal candidiasis (OPC) is among the most common opportunistic infections observed in persons infected with human immunodeficiency virus. A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a novel delivery system with potent in vitro activity against many Candida species, including some that may be resistant to other azoles. MBT, although more expensive, offers an effective, safe, and well-tolerated topical treatment option for OPC that is administered as a convenient once-daily dose.

Original languageEnglish (US)
Pages (from-to)1480-1484
Number of pages5
JournalClinical Infectious Diseases
Volume54
Issue number10
DOIs
Publication statusPublished - May 15 2012
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this